Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05887622 · ClinicalTrials.gov registry record · NA
The Potassium Supplementation Study
A NA study of Cardiovascular Risk Factor and Cardiovascular Health, sponsored by University of Delaware.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT05887622 is a NA study of Cardiovascular Risk Factor and Cardiovascular Health that is actively recruiting participants, run by University of Delaware. The registered enrollment target is 30 participants, below the 3,067-participant average among 31 other Cardiovascular Risk Factor trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05887622, a NA study of Cardiovascular Risk Factor and Cardiovascular Health, is actively recruiting participants, sponsored by University of Delaware.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will test whether potassium supplementation can reduce the deleterious effect of a high sodium diet on blood vessel function, blood pressure reactivity and autonomic nervous system function in apparently healthy adults.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Potassium chloride supplement
Study Locations (1)
Delaware
- Tower at STAR - Newark
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2022-01-24 |
| Est. Completion | 2026-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05887622
The ClinicalTrials.gov registry entry for NCT05887622 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,067-participant average among 31 other Cardiovascular Risk Factor trials with a reported enrollment target (99% lower). The listed sponsor is University of Delaware, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cardiovascular Risk Factor appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT05887622 reports 1 study location spanning 1 distinct geographic area - top geographies include Delaware.
Frequently Asked Questions
What is clinical trial NCT05887622 about?
NCT05887622 is a clinical study titled "The Potassium Supplementation Study". This study will test whether potassium supplementation can reduce the deleterious effect of a high sodium diet on blood vessel function, blood pressure reactivity and autonomic nervous system function in apparently healthy adults.
What is the current status of trial NCT05887622?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2022-01-24. Estimated completion is 2026-01-31.
What conditions does trial NCT05887622 study?
This clinical trial studies the following conditions: Cardiovascular Risk Factor, Cardiovascular Health.
What interventions are being tested in trial NCT05887622?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Potassium chloride supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05887622?
This trial is sponsored by University of Delaware, which has 106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05887622 being conducted?
This trial has 1 study location across Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Risk Factor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
RECRUITING · NA
-
The Influence of Mitochondrial-Derived Reactive Oxygen Species on Racial Disparities in Neurovascular Function
RECRUITING · NA
-
Sleep Duration and Cardiovascular Health
RECRUITING · NA
-
Mechanisms Underlying the Protective Vascular Effects of Dietary Potassium in Humans
RECRUITING · NA
-
Consumption of Oral Artificial Sweeteners on Platelet Aggregation and Polyol Excretion
ACTIVE NOT RECRUITING · NA
-
Short-Term Cardiovascular Effects of E-Cigarettes: Influence of Device Power
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.